Literature DB >> 22791210

Next-generation sequencing in health-care delivery: lessons from the functional analysis of rhodopsin.

Wayne I L Davies1, Susan M Downes, Josephine K Fu, Morag E Shanks, Richard R Copley, Stefano Lise, Simon C Ramsden, Graeme C M Black, Kate Gibson, Russell G Foster, Mark W Hankins, Andrea H Németh.   

Abstract

PURPOSE: The interpretation of genetic information has always been challenging, but next-generation sequencing produces data on such a vast scale that many more variants of uncertain pathogenicity will be found. We exemplify this issue with reference to human rhodopsin, in which pathogenic mutations can lead to autosomal dominant retinitis pigmentosa.
METHODS: Rhodopsin variants, with unknown pathogenicity, were found in patients by next-generation and Sanger sequencing and a multidisciplinary approach was used to determine their functional significance.
RESULTS: Four variants in rhodopsin were identified: F45L, P53R, R69H, and M39R, with the latter two substitutions being novel. We investigated the cellular transport and photopigment function of all four human substitutions and found that the F45L and R69H variants behave like wild-type and are highly unlikely to be pathogenic. By contrast, P53R (a de novo change) and M39R were retained in the endoplasmic reticulum with significantly reduced functionality and are clearly pathogenic.
CONCLUSION: Potential pathogenicity of variants requires careful assessment using clinical, genetic, and functional data. We suggest that a multidisciplinary pathway of assessment, using several functional assays, will be required if next-generation sequencing is to be used effectively, reliably, and safely in the clinical environment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22791210     DOI: 10.1038/gim.2012.73

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  19 in total

1.  Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease.

Authors:  Benjamin M Scott; Steven K Chen; Nihar Bhattacharyya; Abdiwahab Y Moalim; Sergey V Plotnikov; Elise Heon; Sergio G Peisajovich; Belinda S W Chang
Journal:  Genetics       Date:  2018-12-04       Impact factor: 4.562

2.  Mutation analysis of TGFBI and KRT12 in a case of concomitant keratoconus and granular corneal dystrophy.

Authors:  Xianli Du; Peng Chen; Dapeng Sun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-31       Impact factor: 3.117

3.  Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease.

Authors:  Morag E Shanks; Susan M Downes; Richard R Copley; Stefano Lise; John Broxholme; Karl Az Hudspith; Alexandra Kwasniewska; Wayne Il Davies; Mark W Hankins; Emily R Packham; Penny Clouston; Anneke Seller; Andrew Om Wilkie; Jenny C Taylor; Jiannis Ragoussis; Andrea H Németh
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

Review 4.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

5.  Genomic evidence for rod monochromacy in sloths and armadillos suggests early subterranean history for Xenarthra.

Authors:  Christopher A Emerling; Mark S Springer
Journal:  Proc Biol Sci       Date:  2015-02-07       Impact factor: 5.349

6.  Mutations of 60 known causative genes in 157 families with retinitis pigmentosa based on exome sequencing.

Authors:  Yan Xu; Liping Guan; Tao Shen; Jianguo Zhang; Xueshan Xiao; Hui Jiang; Shiqiang Li; Jianhua Yang; Xiaoyun Jia; Ye Yin; Xiangming Guo; Jun Wang; Qingjiong Zhang
Journal:  Hum Genet       Date:  2014-06-18       Impact factor: 4.132

7.  The Retinitis Pigmentosa-Linked Mutations in Transmembrane Helix 5 of Rhodopsin Disrupt Cellular Trafficking Regardless of Oligomerization State.

Authors:  D Paul Mallory; Elizabeth Gutierrez; Margaret Pinkevitch; Christie Klinginsmith; William D Comar; Francis J Roushar; Jonathan P Schlebach; Adam W Smith; Beata Jastrzebska
Journal:  Biochemistry       Date:  2018-08-21       Impact factor: 3.162

8.  De novo point mutations in patients diagnosed with ataxic cerebral palsy.

Authors:  Ricardo Parolin Schnekenberg; Emma M Perkins; Jack W Miller; Wayne I L Davies; Maria Cristina D'Adamo; Mauro Pessia; Katherine A Fawcett; David Sims; Elodie Gillard; Karl Hudspith; Paul Skehel; Jonathan Williams; Mary O'Regan; Sandeep Jayawant; Rosalind Jefferson; Sarah Hughes; Andrea Lustenberger; Jiannis Ragoussis; Mandy Jackson; Stephen J Tucker; Andrea H Németh
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

9.  Targeted next-generation sequencing reveals novel USH2A mutations associated with diverse disease phenotypes: implications for clinical and molecular diagnosis.

Authors:  Xue Chen; Xunlun Sheng; Xiaoxing Liu; Huiping Li; Yani Liu; Weining Rong; Shaoping Ha; Wenzhou Liu; Xiaoli Kang; Kanxing Zhao; Chen Zhao
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

10.  Rhodopsin F45L Allele Does Not Cause Autosomal Dominant Retinitis Pigmentosa in a Large Caucasian Family.

Authors:  Andrea L Vincent; Joseph Carroll; Gerald A Fishman; Alexandra Sauer; Dianne Sharp; Phyllis Summerfelt; Vesper Williams; Adam M Dubis; Susanne Kohl; Fulton Wong
Journal:  Transl Vis Sci Technol       Date:  2013-03-13       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.